CRP and myocardial infarction: CRP apheresis was applied in patients with ST-elevation myocardial infarction (STEMI) (CAMI-1 trial: “Selective depletion of C-reactive protein by therapeutic apheresis (CRP apheresis) in acute myocardial infarction”, DRKS ID: DRKS00008988).